![Jonathan Wygant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Wygant
Comptroller/Controller/Auditor bij
VERACYTE, INC.
Vermogen: 2 M $ op 30-09-2026
Profiel
Jonathan Wygant is currently Chief Accounting Officer & Vice President at Veracyte, Inc. since 2022.
Formerly, Mr. Wygant was Finance Director-Medical Products Segment at Cardinal Health, Inc., Chief Accounting Officer, SVP-Finance & Controller at Alere, Inc. from 2016 to 2017, Finance Manager at CareFusion 303, Inc. in 2004, Senior Auditor at PricewaterhouseCoopers LLP, Chief Accounting Officer, Senior VP & Controller at CareFusion Corp.
from 2009 to 2016, Chief Accounting Officer, VP & Controller at Cibus Corp.
from 2018 to 2020, Chief Accounting Officer at Cibus Ltd. from 2018 to 2020, and Controller at Biosplice Therapeutics, Inc. Education includes undergraduate studies at the University of San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERACYTE, INC. 0,05% | 28-10-2026 | 41.920 ( 0,05% ) | 2 M $ | 30-09-2026 |
Actieve functies van Jonathan Wygant
| Bedrijven | Functie | Begin |
|---|---|---|
| VERACYTE, INC. | Comptroller/Controller/Auditor | 22-02-2022 |
Eerdere bekende functies van Jonathan Wygant
| Bedrijven | Functie | Einde |
|---|---|---|
| CALYXT, INC. | Financieel Directeur/CFO | - |
Cibus Ltd.
 Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Comptroller/Controller/Auditor | 01-10-2020 |
| ALERE INC | Financieel Directeur/CFO | 01-10-2017 |
| CAREFUSION CORPORATION | Comptroller/Controller/Auditor | 01-01-2016 |
CareFusion 303, Inc.
 CareFusion 303, Inc. Medical SpecialtiesHealth Technology Designs, makes and distributes infusion therapy and vital signs measurement instruments | Corporate Officer/Principal | 01-07-2004 |
Opleiding van Jonathan Wygant
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Alere, Inc.
 Alere, Inc. Medical SpecialtiesHealth Technology Manufactures point-of-care diagnostic tests | Health Technology |
CareFusion 303, Inc.
CareFusion 303, Inc. Medical SpecialtiesHealth Technology Designs, makes and distributes infusion therapy and vital signs measurement instruments | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
CareFusion Corp.
 CareFusion Corp. Medical SpecialtiesHealth Technology Manufactures and distributes medical supplies | Health Technology |
Cibus Corp.
 Cibus Corp. BiotechnologyHealth Technology Operates as an agricultural technology company that develops gene edited plant traits | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Health Technology |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Health Technology |
